Outcome and patient-reported toxicity in localised prostate cancer treated with dose-escalated hypofractionated intensity-modulated radiotherapy

Publisher： Cambridge University Press

E-ISSN： 1467-1131|12|4|326-333

ISSN： 1460-3969

Source： Journal of Radiotherapy in Practice, Vol.12, Iss.4, 2013-04, pp. : 326-333

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Impact of obesity on outcomes after definitive dose‐escalated intensity‐modulated radiotherapy for localized prostate cancer

By  

CANCER, Vol. 121, Iss. 17, 2015-09 ,pp. : 3010-3017

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparative effectiveness study of patient‐reported outcomes after proton therapy or intensity‐modulated radiotherapy for prostate cancer

By  

CANCER, Vol. 120, Iss. 7, 2014-04 ,pp. : 1076-1082

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hypofractionated helical intensity-modulated radiotherapy (75 Gy at 2.5 Gy/fraction) for intermediate- and high-risk prostate cancer: Assessment of toxicity

By  

Journal of Radiotherapy in Practice, Vol. 11, Iss. 3, 2012-09 ,pp. : 145-154

Cambridge University Press

Access to resources Recommend Favorite

Cost‐effectiveness analysis of intensity‐modulated radiation therapy with normal and hypofractionated schemes for the treatment of localised prostate cancer

By  

EUROPEAN JOURNAL OF CANCER CARE (ELECTRONIC), Vol. 27, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Preliminary patient‐reported outcomes analysis of 3‐dimensional radiation therapy versus intensity‐modulated radiation therapy on the high‐dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial

By  

CANCER, Vol. 121, Iss. 14, 2015-07 ,pp. : 2422-2430

John Wiley & Sons Inc

Access to resources Recommend Favorite